Dr. Robert N. Weinreb, MD

Dr. Weinreb practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Weinreb's NPI, 1093764177, was assigned on May 8, 2006. Dr. Weinreb graduated from Harvard Medical School in 1975. Dr. Weinreb's California license number on file is G33398.

Dr. Weinreb's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Weinreb's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Weinreb is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinreb practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Weinreb's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Weinreb is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Weinreb has a license on file in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, glaucoma, glaucoma surgery and secondary membranaous cataract surgery among the conditions Dr. Weinreb treats.

CMS data shows 5,229 Medicare services from Dr. Weinreb across 22 procedure codes in 2024, for 1,073 Medicare patients. Medicare paid $439,411 for them.

CMS counts 1,073 Medicare patients who saw Dr. Weinreb in 2024. The largest group is 75 to 84, with 488 patients. 74% of them have high cholesterol, and 66% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weinreb's median patient age at 72, with 49% women.

In 2024, Dr. Weinreb wrote 2,462 Medicare Part D claims for 663 patients. 54% of them were for generic drugs. CMS names the drug for 2,399 of them, across 19 drugs with 11 or more claims each, at $206,022 in total drug cost. In 2023, CMS named 1,837 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Weinreb for performance year 2024, reported as part of a group. Dr. Weinreb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 111 procedures of cataract surgery by Dr. Weinreb, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 935 papers to Dr. Weinreb, published from 2005 to 2025. 2022 was the busiest year, with 51. The most frequent topics are Intraocular Pressure, Glaucoma and Glaucoma, Open-Angle. Dr. Weinreb has published most often in Am J Ophthalmol. Dr. Weinreb's most frequent co-authors are Felipe Andrade Medeiros, MD, Jeffrey M. Liebmann, MD and Christopher Anthony Girkin, MD.

CMS Open Payments shows 477 general payments to Dr. Weinreb from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Topcon Medical Systems, Inc. paid the most, $294,567. It also lists 4 research payments totaling $5,889 from 2016 to 2019.

Dmand AI lists 7 awards for Dr. Weinreb, most recently Guest of Honor in 2024.

Dr. Weinreb graduated from Harvard Medical School in 1975. Dr. Weinreb is a member of AAO.

Dr. Weinreb is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.